Rocket Pharmaceuticals, Inc. Investment Income, Interest
Rocket Pharmaceuticals, Inc. (RCKT) reported Investment Income, Interest of $459.00 thousand for the 3-month period ending 2018-09-30, per its 10-Q filed 2018-11-09.
Discontinued › Income Statement › Other Income
us-gaap:InvestmentIncomeInterest · last filed 2018-11-09
- Rocket Pharmaceuticals, Inc. investment income, interest for the quarter ending 2018-09-30 was $459.00K, a 22850.00% increase year-over-year.
- Rocket Pharmaceuticals, Inc. investment income, interest for the quarter ending 2018-06-30 was $473.00K.
- Rocket Pharmaceuticals, Inc. investment income, interest for the quarter ending 2018-03-31 was $288.00K.
- Rocket Pharmaceuticals, Inc. investment income, interest for the quarter ending 2017-12-31 was $817.00K, a 417.09% increase year-over-year.
- Rocket Pharmaceuticals, Inc. investment income, interest for fiscal 2017 was $819.00K, a 84.88% increase from fiscal 2016.
- Rocket Pharmaceuticals, Inc. investment income, interest for fiscal 2016 was $443.00K, a 397.75% increase from fiscal 2015.
- Rocket Pharmaceuticals, Inc. investment income, interest for fiscal 2015 was $89.00K.
| Period end | Investment Income, Interest 3 month | Investment Income, Interest 3 month as first filed | Investment Income, Interest 6 month | Investment Income, Interest 6 month as first filed | Investment Income, Interest 9 month | Investment Income, Interest 9 month as first filed | Investment Income, Interest 12 month |
|---|---|---|---|---|---|---|---|
| 2018-09-30 | $459.00K 10-Q · filed 2018-11-09 | $932.00K derived: sum of 2 quarters · filed 2018-11-09 | $1.26M 10-Q · filed 2018-11-09 | $2.04M derived: sum of 4 quarters · filed 2018-11-09 | |||
| 2018-06-30 | $473.00K 10-Q · filed 2018-08-14 | $805.00K 10-Q · filed 2018-08-14 | $1.58M derived: sum of 3 quarters · filed 2018-08-14 | $1.58M derived: sum of 4 quarters · filed 2018-11-09 | |||
| 2018-03-31 | $288.00K 10-Q · filed 2018-05-11 | $1.10M derived: sum of 2 quarters · filed 2018-05-11 | $1.11M derived: sum of 3 quarters · filed 2018-11-09 | $1.11M derived: sum of 4 quarters · filed 2018-11-09 | |||
| 2017-12-31 | $817.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-07 | $819.00K derived: sum of 2 quarters · filed 2018-11-09 | $819.00K derived: sum of 3 quarters · filed 2018-11-09 | $819.00K 10-K · filed 2018-03-07 | |||
| 2017-09-30 | $2.00K 10-Q · filed 2018-11-09 | $219.00K 10-Q · filed 2017-11-08 | $2.00K derived: sum of 2 quarters · filed 2018-11-09 | $2.00K 10-Q · filed 2018-11-09 | $574.00K 10-Q · filed 2017-11-08 | $160.00K derived: sum of 4 quarters · filed 2018-11-09 | |
| 2017-06-30 | $0.00 10-Q · filed 2018-08-14 | $183.00K 10-Q · filed 2017-08-03 | $0.00 10-Q · filed 2018-08-14 | $355.00K 10-Q · filed 2017-08-03 | $158.00K derived: sum of 3 quarters · filed 2018-08-14 | $278.00K derived: sum of 4 quarters · filed 2018-08-14 | |
| 2017-03-31 | $0.00 10-Q · filed 2018-05-11 | $172.00K 10-Q · filed 2017-05-10 | $158.00K derived: sum of 2 quarters · filed 2018-05-11 | $278.00K derived: sum of 3 quarters · filed 2018-05-11 | $374.00K derived: sum of 4 quarters · filed 2018-05-11 | ||
| 2016-12-31 | $158.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-07 | $278.00K derived: sum of 2 quarters · filed 2018-03-07 | $374.00K derived: sum of 3 quarters · filed 2018-03-07 | $443.00K 10-K · filed 2018-03-07 | |||
| 2016-09-30 | $120.00K 10-Q · filed 2017-11-08 | $216.00K derived: sum of 2 quarters · filed 2017-11-08 | $285.00K 10-Q · filed 2017-11-08 | $341.00K derived: sum of 4 quarters · filed 2017-11-08 | |||
| 2016-06-30 | $96.00K 10-Q · filed 2017-08-03 | $165.00K 10-Q · filed 2017-08-03 | $221.00K derived: sum of 3 quarters · filed 2017-08-03 | $254.00K derived: sum of 4 quarters · filed 2017-08-03 | |||
| 2016-03-31 | $69.00K 10-Q · filed 2017-05-10 | $125.00K derived: sum of 2 quarters · filed 2017-05-10 | $158.00K derived: sum of 3 quarters · filed 2017-05-10 | ||||
| 2015-12-31 | $56.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | $89.00K derived: sum of 2 quarters · filed 2017-03-16 | $89.00K 10-K · filed 2017-03-16 | ||||
| 2015-09-30 | $33.00K 10-Q · filed 2016-11-09 | $33.00K 10-Q · filed 2016-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| Perspective Therapeutics, Inc. (CATX) | United States | $0.284B | -3.34 |
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Sagimet Biosciences Inc. (SGMT) | United States | $0.279B | |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |